carbapenems has been researched along with kanamycin a in 3 studies
| Studies (carbapenems) | Trials (carbapenems) | Recent Studies (post-2010) (carbapenems) | Studies (kanamycin a) | Trials (kanamycin a) | Recent Studies (post-2010) (kanamycin a) |
|---|---|---|---|---|---|
| 7,355 | 147 | 5,277 | 7,169 | 187 | 946 |
| Protein | Taxonomy | carbapenems (IC50) | kanamycin a (IC50) |
|---|---|---|---|
| 3-oxoacyl-[acyl-carrier-protein] synthase 3 | Escherichia coli K-12 | 6.8 | |
| Gap junction beta-2 protein | Homo sapiens (human) | 9.4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bonnin, RA; Guet-Revillet, H; Nordmann, P; Ocampo-Sosa, AA; Poirel, L | 1 |
| Ahmad, N; Ahuja, SD; Akkerman, OW; Alffenaar, JC; Anderson, LF; Baghaei, P; Bang, D; Barry, PM; Bastos, ML; Behera, D; Benedetti, A; Bisson, GP; Boeree, MJ; Bonnet, M; Brode, SK; Brust, JCM; Cai, Y; Caumes, E; Cegielski, JP; Centis, R; Chan, ED; Chan, PC; Chang, KC; Charles, M; Cirule, A; D'Ambrosio, L; Dalcolmo, MP; de Vries, G; Dheda, K; Esmail, A; Flood, J; Fox, GJ; Fréchet-Jachym, M; Fregona, G; Gayoso, R; Gegia, M; Gler, MT; Gu, S; Guglielmetti, L; Holtz, TH; Hughes, J; Isaakidis, P; Jarlsberg, L; Kempker, RR; Keshavjee, S; Khan, FA; Kipiani, M; Koenig, SP; Koh, WJ; Kritski, A; Kuksa, L; Kvasnovsky, CL; Kwak, N; Lan, Z; Lange, C; Laniado-Laborín, R; Lee, M; Leimane, V; Leung, CC; Leung, EC; Li, PZ; Lowenthal, P; Maciel, EL; Marks, SM; Mase, S; Mbuagbaw, L; Menzies, D; Migliori, GB; Milanov, V; Miller, AC; Mitnick, CD; Modongo, C; Mohr, E; Monedero, I; Nahid, P; Ndjeka, N; O'Donnell, MR; Padayatchi, N; Palmero, D; Pape, JW; Podewils, LJ; Reynolds, I; Riekstina, V; Robert, J; Rodriguez, M; Schnippel, K; Seaworth, B; Seung, KJ; Shim, TS; Singla, R; Smith, SE; Sotgiu, G; Sukhbaatar, G; Tabarsi, P; Tiberi, S; Trajman, A; Trieu, L; Udwadia, ZF; van der Werf, TS; Veziris, N; Viiklepp, P; Vilbrun, SC; Walsh, K; Westenhouse, J; Yew, WW; Yim, JJ; Zetola, NM; Zignol, M | 1 |
| Hu, J; Huang, G; Liang, W; Liu, X; Shang, Y; Shi, H; Wang, Y; Yang, L; Zhang, Y; Zhao, C; Zhu, W; Zhuang, W | 1 |
1 review(s) available for carbapenems and kanamycin a
| Article | Year |
|---|---|
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis.
Topics: Amikacin; Antitubercular Agents; Capreomycin; Carbapenems; Clofazimine; Diarylquinolines; Drug Therapy, Combination; Fluoroquinolones; Humans; Kanamycin; Levofloxacin; Linezolid; Moxifloxacin; Recurrence; Treatment Failure; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2018 |
2 other study(ies) available for carbapenems and kanamycin a
| Article | Year |
|---|---|
Biochemical and genetic characterization of carbapenem-hydrolyzing β-lactamase OXA-229 from Acinetobacter bereziniae.
Topics: Acinetobacter; beta-Lactamases; Carbapenems; Kanamycin; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Phylogeny; Real-Time Polymerase Chain Reaction; Ticarcillin; Transcription Initiation Site | 2012 |
Anti‑restriction protein KlcAHS enhances carbapenem resistance.
Topics: Carbapenems; Drug Resistance, Microbial; Gene Expression Regulation, Bacterial; Genes, Bacterial; Imipenem; Kanamycin; Klebsiella; Microbial Sensitivity Tests; Plasmids; RNA, Messenger; Viral Proteins | 2020 |